Literature DB >> 27275429

Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus.

Erdinc Aydin1, Semsettin Sahin2.   

Abstract

AIM: To report the association between melatonin levels in aqueous humor and serum, and diabetic retinopathy (DR) grade in type 2 diabetic patients.
METHODS: Aqueous humor and plasma samples from 26 patients with DR (in nonproliferative and proliferative stages) and 14 control subjects were collected during cataract surgery after 6 p.m. Melatonin concentrations were determined using an enzyme-linked immunosorbent assay (ELISA).
RESULTS: Melatonin levels were significantly higher in the aqueous humor of patients with proliferative diabetic retinopathy (PDR) [18.57±2.67 pg/mL (range 15.20-23.06) vs 13.63±2.71 pg/mL (range 10.20-20.20), P=0.0001], but not in those with nonproliferative retinopathy (NPDR) [13.79±2.56 pg/mL (range 9.80-20.10) vs 13.63±2.71 pg/mL (range 10.20-20.20), P=0.961] compared to controls. There was decrement in the plasma melatonin level of patients with PDR, but no significant differences between the plasma melatonin levels of the study groups [5.37±1.74 pg/mL (range 2.85-8.65) vs 6.11±1.90 pg/mL (range 3.13-9.41), P=0.293], or between control and DR groups [NPDR 6.11±1.90 pg/mL (range 3.13-9.41) vs control 6.15±1.91 pg/mL (range 2.18-9.86); PDR (5.37±1.74 pg/mL (range 2.85-8.65) vs control 6.15±1.91 pg/mL (range 2.18-9.86), P=0.808, P=0.264].
CONCLUSION: Elevated melatonin levels in aqueous humor in PDR may indicate the level to be associated with DR severity.

Entities:  

Keywords:  aqueous humor; diabetes mellitus; diabetic retinopathy; melatonin

Year:  2016        PMID: 27275429      PMCID: PMC4886868          DOI: 10.18240/ijo.2016.05.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  34 in total

1.  Melatonin concentrations in aqueous humor of glaucoma patients.

Authors:  Christophe Chiquet; Bruno Claustrat; Gilles Thuret; Jocelyne Brun; Howard M Cooper; Philippe Denis
Journal:  Am J Ophthalmol       Date:  2006-08       Impact factor: 5.258

2.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

Review 3.  Protective effects of melatonin in experimental free radical-related ocular diseases.

Authors:  Andrew W Siu; Maria Maldonado; Marina Sanchez-Hidalgo; Dun-Xian Tan; Russel J Reiter
Journal:  J Pineal Res       Date:  2006-03       Impact factor: 13.007

4.  Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.

Authors:  Elmar Peschke; Thomas Frese; Erik Chankiewitz; Dorothee Peschke; Uwe Preiss; Ulrich Schneyer; Rainer Spessert; Eckhard Mühlbauer
Journal:  J Pineal Res       Date:  2006-03       Impact factor: 13.007

Review 5.  Melatonin, longevity and health in the aged: an assessment.

Authors:  Russel J Reiter; Dun-Xian Tan; Juan C Mayo; Rosa M Sainz; Silvia Lopez-Burillo
Journal:  Free Radic Res       Date:  2002-12

Review 6.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

7.  Melatonin in the lacrimal gland: first demonstration and experimental manipulation.

Authors:  M C Mhatre; A S van Jaarsveld; R J Reiter
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

8.  Localization of melatonin receptor 1 in mouse retina and its role in the circadian regulation of the electroretinogram and dopamine levels.

Authors:  Anamika Sengupta; Kenkichi Baba; Francesca Mazzoni; Nikita V Pozdeyev; Enrica Strettoi; P Michael Iuvone; Gianluca Tosini
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

9.  Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy.

Authors:  Taiichi Hikichi; Naohiro Tateda; Toshiaki Miura
Journal:  Clin Ophthalmol       Date:  2011-05-19

10.  Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage.

Authors:  Richard B Rosen; Dan-Ning Hu; Min Chen; Steven A McCormick; Joseph Walsh; Joan E Roberts
Journal:  Mol Vis       Date:  2012-06-20       Impact factor: 2.367

View more
  2 in total

Review 1.  Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs.

Authors:  Ashay D Bhatwadekar; Varun Rameswara
Journal:  Expert Opin Investig Drugs       Date:  2020-12-02       Impact factor: 6.206

Review 2.  Effects of Melatonin on Diabetic Neuropathy and Retinopathy.

Authors:  Klausen Oliveira-Abreu; José Cipolla-Neto; Jose Henrique Leal-Cardoso
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.